Showing 101 - 120 of 129 results.
The distance of the closest surgical margin from the invasive or in situ carcinoma after surgical cancer treatment, measured in...
The response of the tumour at the completion of the initial treatment modalities, as represented by a code.
The systemic therapy agent or protocol administered during the initial course of treatment for cancer, as represented by text.
The completion date of immunotherapy administered during the course of treatment for cancer, expressed as DDMMYYYY.
The received dose of radiation measured in Gray (Gy) - ICRU.
The completion date of immunotherapy administered during the initial course of treatment for cancer, expressed as DDMMYYYY.
The completion date of the radiotherapy administered during the course of treatment for cancer, expressed as DDMMYYYY.
The chemotherapeutic agent or anti-cancer drug used for treatment of the primary cancer, as represented by a code.
The type of radiotherapy administered during the course of treatment for cancer, as represented by a code.
An indicator of whether residual tumour is present after the course of treatment for cancer, as represented by a code.
The start date of the radiotherapy administered during the initial course of treatment for cancer, expressed as DDMMYYYY.
The start date of immunotherapy administered during the initial course of treatment for cancer, expressed as DDMMYYYY.
The completion date of the radiotherapy administered during the initial course of treatment for cancer, expressed as DDMMYYYY.
The type of radiotherapy administered during the initial course of treatment for cancer, as represented by a code.
The total number of radiotherapy sessions (fractions) administered during the course of treatment for cancer.
The eviQ protocol identifier for the systemic therapy agent protocol administered during the course of treatment for cancer.
The type of tumour that remains after the course of cancer treatment, as represented by a code.
The largest prescribed dose of radiation administered during the course of treatment for cancer, measured in Gray (Gy).
The target site of radiotherapy administered during the course of treatment for cancer, as represented by a code.
The systemic therapy agent or protocol administered during the course of treatment for cancer, as represented by text.